909135-31-5 Usage
Uses
Used in Pharmaceutical Research:
Tert-Butyl7-oxo-3-azabicyclo[3.3.1]nonane-3-carboxylate is utilized as a key building block in pharmaceutical research for its unique structure, which allows for the development of new drug candidates with potential therapeutic applications in treating a range of diseases.
Used in Organic Synthesis:
In the field of organic synthesis, Tert-Butyl7-oxo-3-azabicyclo[3.3.1]nonane-3-carboxylate serves as an important intermediate, facilitating the creation of complex organic molecules and contributing to the advancement of chemical science.
Used in the Production of Biodegradable Polymers:
Tert-Butyl7-oxo-3-azabicyclo[3.3.1]nonane-3-carboxylate is studied for its potential use in the production of biodegradable polymers, which are environmentally friendly materials that can degrade over time, reducing the impact of plastic waste on the environment.
Used as a Synthetic Intermediate in Organic Chemistry:
Tert-Butyl7-oxo-3-azabicyclo[3.3.1]nonane-3-carboxylate is also recognized for its role as a synthetic intermediate in organic chemistry, where it can be used to synthesize a variety of other organic compounds, expanding the scope of chemical products and applications.
Check Digit Verification of cas no
The CAS Registry Mumber 909135-31-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,0,9,1,3 and 5 respectively; the second part has 2 digits, 3 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 909135-31:
(8*9)+(7*0)+(6*9)+(5*1)+(4*3)+(3*5)+(2*3)+(1*1)=165
165 % 10 = 5
So 909135-31-5 is a valid CAS Registry Number.
InChI:InChI=1/C13H21NO3/c1-13(2,3)17-12(16)14-7-9-4-10(8-14)6-11(15)5-9/h9-10H,4-8H2,1-3H3
909135-31-5Relevant articles and documents
Structure-activity studies of 7-heteroaryl-3-azabicyclo[3.3.1]non-6-enes: A novel class of highly potent nicotinic receptor ligands
Breining, Scott R.,Melvin, Matt,Bhatti, Balwinder S.,Byrd, Gary D.,Kiser, Melanie N.,Hepler, Christopher D.,Hooker, Dawn N.,Zhang, Jenny,Reynolds, Leslie A.,Benson, Lisa R.,Fedorov, Nikolai B.,Sidach, Serguei S.,Mitchener, J. Pike,Lucero, Linda M.,Lukas, Ronald J.,Whiteaker, Paul,Yohannes, Daniel
, p. 9929 - 9945 (2013/01/16)
The potential for nicotinic ligands with affinity for the α4β2 or α7 subtypes to treat such diverse diseases as nicotine addiction, neuropathic pain, and neurodegenerative and cognitive disorders has been exhibited clinically for several compounds while p
AZABICYCLOALKANE DERIVATIVES USEFUL AS NICOTINIC ACETYLCHOLINE RECEPTOR AGONISTS
-
Page/Page column 22, 35, (2010/11/23)
Compounds of the formula I or a pharmaceutically acceptable salt thereof: processes for their preparation, pharmaceutical compositions which contain them and their uses in therapy.
